Target intelligence / Profile preview

Mucosal and epithelial surface

Molecular classification
Other
01

Overview

Mucosal and epithelial surfaces represent the primary interface between the host and the external environment, covering the gastrointestinal, respiratory, and urogenital tracts (StatPearls, Physiology, Mucosal Immunity). These surfaces function as a critical biological barrier, utilizing physical junctions between epithelial cells and a protective mucus layer to prevent the entry of pathogens and toxins while allowing for nutrient and gas exchange (PubMed, PMID: 28933186). The mucus layer, primarily composed of mucin glycoproteins, provides lubrication and serves as a medium for immune molecules like secretory IgA (Wikipedia, Mucous membrane). In disease states, the integrity of this barrier is often compromised, leading to conditions such as inflammatory bowel disease, asthma, and increased susceptibility to infections (NIH, The Epithelial Barrier in Disease). While not a single molecular target, these surfaces are essential for drug delivery strategies, including mucoadhesive systems and mucolytic agents like acetylcysteine that modify the physical properties of the mucus layer (PubChem, Acetylcysteine). Therapeutic interventions often focus on restoring barrier function or utilizing the large surface area for systemic drug absorption (PubMed, PMID: 25618728). Consequently, the mucosal and epithelial surface is a key consideration in pharmacology for both local treatment and systemic delivery.

Other names
MucosaMucous membraneEpithelial barrierMucosal barrier
02

Mechanism of action

Modulation of physical barrier properties, mucoadhesion, and lubrication of the epithelial lining.

03

Biological functions

Barrier functionAbsorptionSecretionImmune surveillanceLubrication
04

Disease associations

InfectionInflammationCancerCystic fibrosisInflammatory bowel disease
05

Safety considerations

Mucosal irritationEpithelial erosionDisruption of the commensal microbiomeUnintended systemic absorption
06

Interacting drugs

Acetylcysteine

3 more in the full profile.

07

Biomarkers

Mucin expression (e.g., MUC1, MUC2, MUC5AC)Transepithelial electrical resistance (TEER)Secretory IgA (sIgA)

Beyond the preview

Go deeper on Mucosal and epithelial surface.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mucosal and epithelial surface.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call